Cellulitis of the lower leg of adult patients that have been admitted to Landspitali University Hospital and are on iv antibiotics.
Conditions
Interventions
Trade Name: Tea-Tree m.a. extra
Pharmaceutical Form: Cutaneous liquid
Pharmaceutical form of the placebo: Cutaneous liquid
Route of administration of the placebo: Cutaneous use
Sponsors
University of Iceland
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. patient with cellulitis of class II in the Eron/Dall classification system for cellulitis 2. patient on iv antibiotics 3. patient who gets admitted to one of the general medicine wards 4. patient who writes and understands icelandic 5. patient who can give written and informed concent to participate in the clinical trial 6. patient admitted for at least six days or for the length of the treatment period 7. patient with no history of any allergies 8. patient who has not used any antibiotic, inflammatory or steroid cream on the diseased leg one day prior admission Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria: 1. childbearing or lactating women 2. patient with HIV, hepatitis or canser 3. patient with COPD or has FEV1<80% or is taking inhalants 4. patient with impared kidney function or has GFR<60ml/min 5. patient with impaired memory, delerium or dementia 6. patient with psoriasis or stasis dermatitis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: Is to test a new intervention against cellulitis. ;Secondary Objective: To observe if there are any complications of the new treatment.;Primary end point(s): 1. patient has finished five days of treatment with oil application to the leg and has finished all outcome measurements on day six and gotten some information/education from the researcher. The patient drops out of the clinical trial if: 1. patient is discharged to early 2. patient is discharged to a surgical department 3. patient gets any complication or adverse effects because of the new treatment 4. patient dies 5. patient desides to quit participating in the clinical trial 6. patient gets new diagnosis of diseases or any new symptoms | — |
Countries
Iceland
Outcome results
None listed